These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38300516)

  • 1. Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes.
    Akturk HK
    Diabetes Technol Ther; 2024 Jul; 26(7):503-508. PubMed ID: 38300516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose Targets Using Continuous Glucose Monitoring Metrics in Older Adults With Diabetes: Are We There Yet?
    Toschi E; O'Neal D; Munshi M; Jenkins A
    J Diabetes Sci Technol; 2024 Jul; 18(4):808-818. PubMed ID: 38715259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control.
    Herrero P; Alalitei A; Reddy M; Georgiou P; Oliver N
    Diabetes Technol Ther; 2021 Apr; 23(4):314-319. PubMed ID: 33064025
    [No Abstract]   [Full Text] [Related]  

  • 5. The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.
    Toschi E; Slyne C; Sifre K; O'Donnell R; Greenberg J; Atakov-Castillo A; Carl S; Munshi M
    Diabetes Care; 2020 Oct; 43(10):2349-2354. PubMed ID: 32461211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use.
    Akturk HK; Sakamoto C; Vigers T; Shah VN; Pyle L
    J Diabetes Sci Technol; 2023 Sep; ():19322968231200901. PubMed ID: 37747124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of a Machine Learning-Based Decision Rule to Reduce Hypoglycemia Among Older Adults With Type 1 Diabetes: A Post Hoc Analysis of Continuous Glucose Monitoring in the WISDM Study.
    Kahkoska AR; Shah KS; Kosorok MR; Miller KM; Rickels M; Weinstock RS; Young LA; Pratley RE
    J Diabetes Sci Technol; 2024 Sep; 18(5):1079-1086. PubMed ID: 36629330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Feasibility Study of Paired Continuous Glucose Monitoring Intrapartum and in the Newborn in Pregnancies Complicated by Type 1 Diabetes.
    Stewart ZA; Thomson L; Murphy HR; Beardsall K
    Diabetes Technol Ther; 2019 Jan; 21(1):20-27. PubMed ID: 30620640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
    Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review.
    Gómez-Peralta F; Leiva-Gea I; Duque N; Artime E; Rubio de Santos M
    Adv Ther; 2024 Sep; 41(9):3471-3488. PubMed ID: 39093492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a three-dimensional scoring model for the assessment of continuous glucose monitoring data in type 1 diabetes.
    Dawnbringer J; Hill H; Lundgren M; Catrina SB; Caballero-Corbalan J; Cederblad L; Carlsson PO; Espes D
    BMJ Open Diabetes Res Care; 2024 Sep; 12(4):. PubMed ID: 39242123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of continuous glucose monitoring as an outcome measure in clinical trials.
    Beck RW; Calhoun P; Kollman C
    Diabetes Technol Ther; 2012 Oct; 14(10):877-82. PubMed ID: 23013201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
    Gómez AM; Henao DC; Imitola Madero A; Taboada LB; Cruz V; Robledo Gómez MA; Rondón M; Muñoz-Velandia O; García-Jaramillo M; León Vargas FM
    Diabetes Technol Ther; 2019 Aug; 21(8):430-439. PubMed ID: 31219350
    [No Abstract]   [Full Text] [Related]  

  • 18. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration.
    Akturk HK; Herrero P; Oliver N; Wise H; Eikermann E; Snell-Bergeon J; Shah VN
    Diabetes Technol Ther; 2022 Oct; 24(10):749-753. PubMed ID: 35653736
    [No Abstract]   [Full Text] [Related]  

  • 20. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.